Ajanta Pharma Ltd Financials
Company Logo

Ajanta Pharma Ltd Financial Statement

Ajanta Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue1249.19
Operating Expense879.16
Net Profit254.97
Net Profit Margin20.41
Earning Per Share20.41
EBIDTA366.74
Effective Tax Rate19.11

Ajanta Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual4,322.04
Operating Expenses Annual3,117.32
Operating Profit Annual1,324.59
Interest Annual4.60
Depreciation132.79
Net Profit Annual916.89
Tax Annual263.17

Ajanta Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning61.78
Cash Flow from Operations1,053.80
Cash Flow from Investing-349.60
Cash Flow from Financing-715.71
Cash Flow at the End50.27

Ajanta Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)30.65
PBIT Margin (%)27.41
PBT Margin (%)21.45
Net PROFIT Margin (%)21.21
Return On Networth / Equity (%)26.05
Return On Networth /Employed (%)32.78
Return On Assets (%)25.46
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)1.20

Ajanta Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual1,741.96
Total Current Assets Annual2,576.06
Non Current Assets Annual1,978.19
Total Shareholders Funds Annual3,625.31
Total Assets Annual4,554.25

Ajanta Pharma Ltd Earning Calls

EPS (INR)

Expected

20.37

Reported

20.44

Surprise

0.34%

Mar 2025

EPS beaten by 0.34%

Dec 2024

EPS beaten by 0.17%

Sep 2024

EPS beaten by 0.11%

FAQS on Ajanta Pharma Ltd Financials

As of Aug 8, 2025, Ajanta Pharma Ltd has a market capitalization of 32,708.23 Cr. Value Research classifies it as a Large-Cap company.

Yes, Ajanta Pharma Ltd is with a debt-to-equity ratio of 0.01.

In FY 2024 , Ajanta Pharma Ltd recorded a total revenue of approximately 4,322.04 Cr marking a significant milestone in the company's financial performance.

Ajanta Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..

Ajanta Pharma Ltd's current PE ratio is 35.67.

Ajanta Pharma Ltd's ROCE averaged 28.6% from the FY ending March 2023 to 2025, with a median of 32.0%. It peaked at 32.4% in March 2025, reflecting strong capital efficiency over the period..

Ajanta Pharma Ltd's latest EBIT is Rs. 1,184.66 Cr, surpassing the average EBIT of Rs. 997.83 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions